Twice-Daily Cysteamine Trials Update

The Cystinosis Research Foundation has made available the publication of "Long-Term Treatment of Cystinosis in Children with Twice-Daily Cysteamine" by a group of leading researchers, including Dr Ranjan Dohil.

This publication details the results of a long term study of enteric coated Cystagon capsules with a group of cystinotics. The enteric coating is designed to relieve some of the side effects of Cystagon, and reduce both the required dosage and its frequency. This has since led to further development by Raptor Pharmaceuticals who are now in clinical trials with the treatment.

View The Full Publication

Comments are closed.

We’re Looking for New Trustees – Can You Help? Cystinosis Foundation UK is a charity that helps and supports people living with the rare [...] Read more...
Sponsored Walk for Ava The family of Ava, who was diagnosed with cystinosis last December, have organised a sponsored [...] Read more...
Cystinosis Comic Book Series by Artist Kevin McCalla The Cystinosis Research Network in the US has teamed up with Kevin McCalla, a young artist who [...] Read more...
Newsletter – November 2012 Issue 21 of the Foundation newsletter has recently been finalised and is available to download [...] Read more...
All website content copyright Cystinosis Foundation UK (Charity No.1074885) 1997-2013, except where explicitly stated.
Data Protection Act Registration Number: Z9880997. Please refer to our terms and conditions and our privacy policy.
site:bonnyday